See a complete PubMed list of publications by Lali Medina-Kauwe, PhD.

Selected Key Publications

Sims JD, Hwang JY, Wagner S, Alonso-Valenteen F, Hanson C, Taguiam JM, Polo R, Harutyunyan I, Karapetyan G, Sorasaenee K, Ibrahim A, Marban E, Moats R, Gray HB, Gross Z, Medina-Kauwe LK. A corrole nanobiologic elicits tissue-activated MRI contrast enhancement and tumor-targeted toxicity. J Control Release. 2015 Aug 31;217:92-101.

Hwang JY, Farkas DL, Medina-Kauwe LK. Analysis of targeted viral protein nanoparticles delivered to HER2+ tumors. J Vis Exp. 2013 Jun 18;(76).

Medina-Kauwe LK. Development of adenovirus capsid proteins for targeted therapeutic delivery. Ther Deliv. 2013;4(2):267-277.

Hwang JY, Lubow DJ, Chu D, Sims J, Alonso-Valenteen F, Gray HB, Gross Z, Farkas DL, Medina-Kauwe LK. Photoexcitation of tumor-targeted corroles induces singlet oxygen-mediated augmentation of cytotoxicity. J Control Release. 2012;163(3):368-373.

Hwang JY, Park J, Kang BJ, Lubow DJ, Chu D, Farkas DL, Shung KK, Medina-Kauwe LK. Multimodality imaging in vivo for preclinical assessment of tumor-targeted doxorubicin nanoparticles. PLOS One. 2012;7(4):e34463.

Agadjanian H, Chu D, Hwang JY, Wachsmann-Hogiu S, Rentsendorj A, Song L, Valluripalli V, Lubow J, Ma J, Sharifi B, Farkas DL, Medina-Kauwe LK. Chemotherapy targeting by DNA capture in viral protein particles. Nanomedicine. 2012;7(3):335-352.

Hwang JY, Lubow J, Chu D, Ma J, Agadjanian H, Gray HB, Gross Z, Farkas DL, Medina-Kauwe LK. A mechanistic study of tumor-targeted corrole cytotoxicity. Mol Pharm. 2011;8(6):2233-2243.

Agadjanian H, Ma J, Rentsendorj A, Valluripalli V, Hwang JY, Mahammed A, Farkas DL, Gray HB, Gross Z, Medina-Kauwe LK. Tumor detection and elimination by a targeted gallium corrole. Proc Natl Acad Sci USA. 2009;106(15):6105-6110.

Medina-Kauwe LK. "Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery? Adv Drug Deliv Rev. 2007;59(8):798-809.

Xie J, Chiang L, Contreras J, Wu K, Garner JA, Medina-Kauwe L, Hamm-Alvarez SF. Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal acini. J Virol. 2006;80(23):11833-11851.

Rentsendorj A, Xie J, MacVeigh M, Agadjanian H, Bass S, Hamm-Alvarez S, Medina-Kauwe LK. Typical and atypical trafficking pathways of Ad5 penton base recombinant protein: implications for gene transfer. Gene Ther. 2006;13(10):821-836.

Agadjanian H, Weaver JJ, Mahammed A, Rentsendorj A, Bass S, Kim J, Dmochowski IJ, Margalit R, Gray HB, Gross Z, Medina-Kauwe LK. Specific delivery of corroles to cells via noncovalent conjugates with viral proteins. Pharm Res. 2006;23(2):367-377.

Candolfi M, Curtin JF, Xiong W, Kroeger KM, Liu C, Rentsendorj A, Agadjanian H, Medina-Kauwe L, Palmer D, Ng P, et al. Effective High Capacity Gutless Adenoviral Vectors Mediated Transgene Expression in Human Glioma Cells, Molecular Therapy. 2006;14(3):371-81.

Medina-Kauwe LK. Endocytosis of adenovirus and adenovirus capsid proteins. Adv Drug Del Rev. 2003;55(11):1485-1496.

Medina-Kauwe LK, Maguire M, Kasahara N, Kedes L. Non-viral gene delivery to human breast cancer cells by targeted Ad5 penton proteins. Gene Ther. 2001;8(23):1753-1761.